Company Profile

Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it enclosed the result of remote e-voting in the prescribed format along with Scrutinizer's consolidated report for the below resolutions which were proposed for the approval of the Members through Postal Ballot. a. Appointment of Anand Kusre (DIN 00818477) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2024, b. Appointment of Arun Todarwal (DIN 00020916) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2024, c. Material related party transaction(s) with Ipca Laboratories (‘Ipca’), holding company of Unichem Laboratories, d. Material related party transaction(s) between Ipca, holding company of Unichem and Unichem Pharmaceuticals USA Inc. (‘Unichem USA’), wholly owned subsidiary of Unichem, e. Material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. The resolutions as proposed in the postal ballot notice have been passed by the shareholders by remote e-voting process with requisite majority and are deemed to be passed on the last date of the remote e-voting period i.e. Friday, 22nd March 2024. The said results and the scrutinizer’s report will be available on the Company’s website: www.unichemlabs.com and that of the exchanges namely www.bseindia.com and www.nseindia.com and the website of the e-voting agency: www.evotingindia.com.

Unichem Laboratories has informed that it enclosed the Postal Ballot Notice together with the explanatory statement seeking the approval of the members of the Company on the following Special Business items as set out in the Notice dated 5th February, 2024: 1. Special resolution for approval of appointment of Anand Kusre (DIN 00818477) as a Non-Executive Independent Director for a term of five years with effect from 5th February, 2024. 2. Special resolution for approval of appointment of Arun Todarwal (DIN 00020916) as a Non-Executive Independent Director for a term of five years with effect from 5th February, 2024. 3. Ordinary resolution for approval of material related party transaction(s) with Ipca Laboratories (‘Ipca’), holding company of Unichem Laboratories (‘Unichem’). 4. Ordinary resolution for approval of material related party transaction(s) between Ipca, holding company of Unichem and Unichem Pharmaceuticals USA Inc. (‘Unichem USA’), wholly owned subsidiary of Unichem. 5. Ordinary resolution for approval of material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. Notice is being sent through electronic mode to those members whose e-mail addresses are registered with the Company/Depositories and whose names are recorded in the Register of Members of the Company or in the Register of Beneficial Owners maintained by the Depositories as on Friday, 16th February, 2024. The notice is being sent by e-mail on 21st February, 2024 to the members who have registered their e-mail IDs with Depository Participant(s) or with the Company. E-voting period will commence from Thursday, 22nd February, 2024, IST at 9.00 am and will end on Friday, 22nd March, 2024 IST at 5.00 pm. The Notice will also be available on the website of the Company at www.unichemlabs.com and on the website of the Central Depository Services (India) (CDSL) at https://www.evotingindia.com/.

The above information is a part of company’s filings submitted to BSE.